Botox block of the sphenopalatine ganglion in treatment of chronic migraine

Phase 1

• Conditions: Chronic migraine; MedDRA version: 17.0Level: LLTClassification code 10066636Term: Chronic migraineSystem Organ Class: 100000004852; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]

• Registration Number: EUCTR2014-001852-43-NO
• Lead Sponsor: Department of Neuroscience, NT

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-06-12
• Study Completion: 2016-02-01
• Last Update Posted: 19 April 2022

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Informed and written consent
Person from 18 to 65 years old
Refractory chronic migraine
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 8
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 2

Exclusion Criteria

Medication overuse headache
Co-morbidity that significantly increases the risk of the procedure
Pregnancy
Inadequate use of prevention or lactancy
Allergies to local anesthetics or IMP

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified